PATH · XBRL financial data
UiPath financial statements, every quarter
The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (PATH's year ends in late January)
| In millions of dollars | Oct 31, 2023 | Jan 31, 2024 | Apr 30, 2024 | Jul 31, 2024 | Oct 31, 2024 | Jan 31, 2025 | Apr 30, 2025 | Jul 31, 2025 | Oct 31, 2025 | Jan 31, 2026 | Apr 30, 2026 | Jul 31, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from contracts with customers | 326 | 405* | 335 | 316 | 355 | 424* | 357 | 362 | 411 | 481* | 418 | 410 |
| Cost of revenue | 50 | 53* | 55 | 63 | 64 | 65* | 64 | 64 | 69 | 74* | 77 | 81 |
| Gross profit | 276 | 352* | 280 | 253 | 291 | 359* | 293 | 297 | 342 | 407* | 341 | 330 |
| Research and development | 85 | 86* | 86 | 98 | 97 | 100* | 95 | 98 | 97 | 95* | 93 | 83 |
| General and administrative | 56 | 59* | 64 | 64 | 50 | 49* | 55 | 53 | 53 | 54* | 53 | 50 |
| Total operating expenses | 332 | 337* | 329 | 356 | 334 | 326* | 309 | 318 | 329 | 327* | 313 | 298 |
| Operating income (loss) | (56) | 15* | (49) | (103) | (43) | 34* | (16) | (20) | 13 | 80* | 28 | 32 |
| Interest income | 14 | 15* | 14 | 13 | 10 | 12* | 13 | 12 | 12 | 12* | 10 | 11 |
| Other income (expense) | 14 | 6* | 11 | 8 | 8 | 9* | (16) | 12 | (0) | 0* | 3 | 10 |
| Income tax expense (benefit) | 4 | 3* | 4 | 4 | (15) | 3* | 3 | 2 | (174) | (12)* | 18 | 17 |
| Net income (loss) | (32) | 34* | (29) | (86) | (11) | 52* | (23) | 2 | 199 | 104* | 23 | 36 |
| Earnings per share, basic USD per share | (0.06) | 0.06* | (0.05) | (0.15) | (0.02) | 0.09* | (0.04) | 0.00 | 0.37 | 0.19* | 0.04 | 0.07 |
| Earnings per share, diluted USD per share | (0.06) | 0.06* | (0.05) | (0.15) | (0.02) | 0.09* | (0.04) | 0.00 | 0.37 | 0.19* | 0.04 | 0.07 |
| Weighted average shares, basic millions of shares | 567 | 567* | 570 | 568 | 551 | 551* | 548 | 536 | 532 | 536* | 524 | 520 |
| Weighted average shares, diluted millions of shares | 567 | 567* | 570 | 568 | 551 | 551* | 548 | 543 | 539 | 549* | 528 | 523 |
Balance sheet
CSVFiscal quarters (PATH's year ends in late January)
Cash flows
CSVFiscal quarters (PATH's year ends in late January)
| In millions of dollars | Oct 31, 2023 | Jan 31, 2024 | Apr 30, 2024 | Jul 31, 2024 | Oct 31, 2024 | Jan 31, 2025 | Apr 30, 2025 | Jul 31, 2025 | Oct 31, 2025 | Jan 31, 2026 | Apr 30, 2026 | Jul 31, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | (32) | 34* | (29) | (86) | (11) | 52* | (23) | 2 | 199 | 104* | 23 | 36 |
| Stock-based compensation | 96* | 89* | 89 | 94* | 87* | 88* | 76 | 78* | 71* | 65* | 53 | 45* |
| Net cash from operating activities | 42* | 146* | 100 | 46* | 28* | 146* | 119 | 42* | 28* | 182* | 132 | 31* |
| Purchases of property and equipment | 1* | 4* | 1 | 1* | 5* | 7* | 13 | 0* | 3* | 3* | 3 | 1* |
| Net cash from investing activities | (60)* | (9)* | 36 | (42)* | (23)* | (17)* | (80) | (1)* | 101* | (43)* | (113) | (16)* |
| Share repurchases | 53* | 50* | 22 | 197* | 163* | 9* | 228 | 102* | 0* | 0* | 244 | 25* |
| Net cash from financing activities | (69)* | (82)* | (46) | (215)* | (173)* | (17)* | (235) | (112)* | (11)* | (14)* | (252) | (35)* |
| Net change in cash | (91)* | 59* | 85 | (207)* | (166)* | 106* | (179) | (72)* | 115* | 127* | (238) | (25)* |
Compare with peers
SIC 7372 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 7372 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Quarter |
|---|---|---|---|---|---|
| UiPath | 607 | 410 | 31* | not reported | 10-QJul 31, 2026 |
| BILL Holdings | 1,031 | 436* | 111* | 85.3M | 10-KJun 30, 2026 |
| Klaviyo | 833 | 371 | 94* | not reported | 10-QJun 30, 2026 |
| Life360 | 267 | 159 | 24* | 81.5M | 10-QJun 30, 2026 |
| Pegasystems | 202 | 393 | 6.1* | 163.7M | 10-QSep 30, 2026 |
| Science Applications International | 126 | 1,880 | 146* | 41.9M | 10-QJul 31, 2026 |
| SentinelOne | 201 | 292 | (6.5)* | not reported | 10-QJul 31, 2026 |
| Box | 343 | 321 | 71* | 137.2M | 10-QJul 31, 2026 |
| SPS Commerce | 154 | 198 | 64* | 35.4M | 10-QSep 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.